HK1005848A1 - Use of esters of acyl l-carnitines with gamma-hydroxybutyric acid for producing pharmaceutical compositions for the treatment of hepatopathies - Google Patents

Use of esters of acyl l-carnitines with gamma-hydroxybutyric acid for producing pharmaceutical compositions for the treatment of hepatopathies

Info

Publication number
HK1005848A1
HK1005848A1 HK98104932A HK98104932A HK1005848A1 HK 1005848 A1 HK1005848 A1 HK 1005848A1 HK 98104932 A HK98104932 A HK 98104932A HK 98104932 A HK98104932 A HK 98104932A HK 1005848 A1 HK1005848 A1 HK 1005848A1
Authority
HK
Hong Kong
Prior art keywords
hepatopathies
gamma
esters
acyl
pharmaceutical compositions
Prior art date
Application number
HK98104932A
Other languages
English (en)
Inventor
Fabio Zezza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of HK1005848A1 publication Critical patent/HK1005848A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK98104932A 1991-05-15 1998-06-05 Use of esters of acyl l-carnitines with gamma-hydroxybutyric acid for producing pharmaceutical compositions for the treatment of hepatopathies HK1005848A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM910327A IT1248321B (it) 1991-05-15 1991-05-15 Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie

Publications (1)

Publication Number Publication Date
HK1005848A1 true HK1005848A1 (en) 1999-01-29

Family

ID=11400141

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104932A HK1005848A1 (en) 1991-05-15 1998-06-05 Use of esters of acyl l-carnitines with gamma-hydroxybutyric acid for producing pharmaceutical compositions for the treatment of hepatopathies

Country Status (8)

Country Link
US (1) US5246967A (ja)
EP (1) EP0514357B1 (ja)
JP (1) JP3406614B2 (ja)
AT (1) ATE132746T1 (ja)
DE (1) DE69207479T2 (ja)
DK (1) DK0514357T3 (ja)
HK (1) HK1005848A1 (ja)
IT (1) IT1248321B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
IT1263013B (it) * 1992-10-20 1996-07-23 Avantgarde Spa Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.
IT1261432B (it) * 1993-03-26 1996-05-23 Sigma Tau Ind Farmaceuti Uso di acil l- carnitina gammaidrossibutirrato per il trattamento dell'alcolismo.
IT1261984B (it) * 1993-06-22 1996-06-11 Avantgarde Spa Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
IT1261485B (it) * 1993-06-24 1996-05-23 Sigma Tau Ind Farmaceuti Uso di acil l-carnitine gamma-idrossibutirrato per il trattamento di tossicodipendenze.
IT1261828B (it) * 1993-07-14 1996-06-03 Sigma Tau Ind Farmaceuti Esteri di acil l-carnitine e composizioni farmaceutiche che li contengono per il trattamento dello shock endotossico.
IT1277898B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie
IT1306129B1 (it) * 1999-04-13 2001-05-30 Sigma Tau Ind Farmaceuti Esteri della l-carnitina o di alcanoil l-carnitine utilizzabili comelipidi cationici per l'immissione intracellulare di composti
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US20200114015A1 (en) * 2017-04-11 2020-04-16 John K. Thottathil Novel Alpha-Hydroxy Carboxylic Acid And Derivatives And Other GRAS- Based Prodrugs Of Gamma-Hydroxybutyrate (GHB) And Uses Thereof
GB201710229D0 (en) * 2017-06-27 2017-08-09 Tdeltas Ltd Compounds for new use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903579A1 (de) * 1978-02-03 1979-08-09 Sigma Tau Ind Farmaceuti Verwendung von acetylcarnitin und anderen acylderivaten des carnitins zur behandlung der hyperlipoproteinaemie und hyperlimpidaemie sowie arzneimittel
IT1147079B (it) * 1980-05-30 1986-11-19 Sigma Tau Ind Farmacuetiche Ri Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono
EP0059775B1 (de) * 1980-06-09 1984-09-19 Leopold & Co. Chem. pharm. Fabrik Gesellschaft m.b.H. Infusionslösung zum Schutz der Leber und zur Verbesserung von deren Funktion und Verfahren zu deren Herstellung
IT1208753B (it) * 1986-07-02 1989-07-10 Sigma Tau Ind Farmaceuti L-amminoacil derivati della l-carnitina, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' epatoprotettrice che li contengono
IT1240760B (it) * 1990-02-12 1993-12-17 Sigma Tau Ind Farmaceuti Esteri di acil-l-carnitine con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che li contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma.
IT1240775B (it) * 1990-02-23 1993-12-17 Sigma Tau Ind Farmaceuti Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma.

Also Published As

Publication number Publication date
DE69207479T2 (de) 1996-05-23
DE69207479D1 (de) 1996-02-22
US5246967A (en) 1993-09-21
EP0514357A1 (en) 1992-11-19
JPH05163141A (ja) 1993-06-29
IT1248321B (it) 1995-01-05
DK0514357T3 (da) 1996-02-26
ITRM910327A1 (it) 1992-11-15
ATE132746T1 (de) 1996-01-15
JP3406614B2 (ja) 2003-05-12
ITRM910327A0 (it) 1991-05-15
EP0514357B1 (en) 1996-01-10

Similar Documents

Publication Publication Date Title
HK1005848A1 (en) Use of esters of acyl l-carnitines with gamma-hydroxybutyric acid for producing pharmaceutical compositions for the treatment of hepatopathies
HK1005849A1 (en) Use of l-carnitine derivatives for the manufacture of a medicament for the therapeutical treatment of peripheral neuropathies
DE69305540D1 (de) Ester des Acyl-Carnitins mit langkettigen aliphatischen Alkoholen und diese enthaltende pharmazeutische Zusammensetzungen mit antibakterieller Wirkung
HUT46536A (en) Process for producing antianxietive pharmaceutical compositions
HUT63615A (en) Process for producing new imidazole derivatives and pharmaceutical compositions comprising same as active ingredient
LV10235B (en) New esters, method of preparation thereof, pharmaceutical composition and method of treatment
EP0311068A3 (en) Polyamine derivatives as antineoplastic agents
DE69313325D1 (de) Ester von L-Carnitin und Acyl-L-Carnitin, mit entspannender Wirkung, selektiv auf den Gastrointestinaltrakt und sie enthaltende pharmazeutische Zusammensetzungen
HUT70757A (en) Pharmaceutical compositions for treating skin disorders
NZ214640A (en) Trienamide derivatives and pharmaceutical compositions having anti-inflammatory and analgesic activity
ATE193521T1 (de) Carnitine-bisalkanoylester mit bakterizider, fungizider und antiprotozoischer wirkung
GR3017801T3 (en) Flavone derivatives.
EP0322248A3 (en) Compounds effective against cerebral insufficiency
HU9203052D0 (en) Method for treatment of hypertension
HUT59598A (en) Process for producing preventive pharmaceutical compositions against myocardial ischemie
HK1009326A1 (en) Use of acyl l-carnitine gamma-hydroxybutyrate for the treatment of alcoholism

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060512